Abstracts
A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection
Background
Although micronutrient and antioxidant supplementation are widely used by persons with human immunodeficiency virus (HIV), a therapeutic role beyond recommended daily allowances (RDA) remains unproven. An oral high-dose micronutrient and antioxidant supplement (Treatment) was compared to an RDA supplement (Control) for time to progressive immunodeficiency or initiation of antiretroviral therapy (ART) in people living with HIV (PLWH).
Abstracts
Knowledge of safety and herb-drug interations amongst HIV+ individuals: a focus group study.
Abstracts
Vitamin supplementation for prevention of mother-to-child transmission of HIV and pre-term delivery: a systematic review.
Abstracts
African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology.
Abstracts
Acupuncture for treatment of HIV associated acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome)
Abstracts
Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.
Abstracts
Micronutrient Deficiency and Treatment Adherence in a Randomized Controlled Trial of Micronutrient Supplementation in ART-Naive Persons with HIV
Abstracts
Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians
Objectives
Based on a growing body of evidence implicating low vitamin D status in the development of cardiovascular disease (CVD), we hypothesized that in Canadian HIV-positive adults, low 25-hydroxyvitamin D (25(OH)D) concentration would be associated with increased subclinical vascular disease progression.
Methods